Company intelligence / Profile preview
CMOL Pharmaceuticals Australia
Melbourne, Victoria, Australiacmolpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CMOL Pharmaceuticals is an Australian biopharmaceutical company focused on the development and commercialization of cannabinoid-based medicines. The company specializes in creating high-quality, pharmaceutical-grade formulations designed to treat conditions such as chronic pain, anxiety, and neurological disorders. CMOL leverages clinical research to validate the efficacy of its products and aims to provide standardized treatment options within the medicinal cannabis sector. Their operations include the distribution of proprietary formulations to patients through authorized medical channels in Australia and international markets.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on CMOL Pharmaceuticals Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CMOL Pharmaceuticals Australia.